NULL
New Jersey

Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration

WARREN, , Feb. 15, 2018 /PRNewswire/ -- Celularity has been created through the contribution and acquisition of extensive intellectual property, clinical-stage assets, basic and clinical research, and product development expertise including:…
Continue Reading »
New Jersey

Inaugural “Pathways in Reproductive Medicine” educational program supports OB/GYN residents interested in Reproductive Endocrinology and Infertility (REI)

BASKING RIDGE, , Feb. 15, 2018 /PRNewswire/ -- Reproductive Medicine Associates of New Jersey (RMANJ), presents the inaugural "Pathways in Reproductive Medicine" educational program for OB/GYN residents interested in learning…
Continue Reading »
New Jersey

Gary Bailer, Director of Product Management, Pro AV Products of Sharp Electronics, Recognized as 2018 CRN® Channel Chief

MONTVALE, , Feb. 15, 2018 /PRNewswire/ -- Sharp Imaging and Information Company of America (SIICA), a division of Sharp Electronics Corporation (SEC) announced today that CRN®, a brand of The Channel…
Continue Reading »
New Jersey

Positive Phase 3 Trial Results of Investigational Anticancer Agent Lenvatinib in Unresectable Hepatocellular Carcinoma (HCC) Published in The Lancet

WOODCLIFF LAKE, , Feb. 15, 2018 /PRNewswire/ -- Eisai Inc. announced today that the positive results of a Phase 3 study (REFLECT study, Study 304) of its in-house discovered and developed…
Continue Reading »